In Reply

Affiliations

Comment

Ashten Waks et al. Obstet Gynecol. 2019 Jan.

. 2019 Jan;133(1):188-189.

doi: 10.1097/AOG.0000000000003031.

¹ Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, California.

No abstract available

Comment on

Balloon Uterine Tamponade Device After Peripartum Hysterectomy for Morbidly Adherent Placenta.
Waks A, Tabsh K, Tabsh K, Afshar Y. Waks A, et al. Obstet Gynecol. 2018 Sep;132(3):643-646. doi: 10.1097/AOG.0000000000002792. Obstet Gynecol. 2018. PMID: 30095778
Balloon Uterine Tamponade Device After Peripartum Hysterectomy for Morbidly Adherent Placenta.
Matsubara S. Matsubara S. Obstet Gynecol. 2019 Jan;133(1):188. doi: 10.1097/AOG.0000000000003030. Obstet Gynecol. 2019. PMID: 30575658 No abstract available.

1. Waks A, Tabsh K, Tabsh K, Afshar Y. Balloon uterine tamponade device after peripartum hysterectomy for morbidly adherent placenta. Obstet Gynecol 2018;132:643–6.
1. Charoenkwan K. Effective use of the Bakri postpartum balloon for posthysterectomy pelvic floor hemorrhage. Am J Obstet Gynecol 2014;210:586.e1–3.
1. Silver R, Ware Branch D. Placenta accrete spectrum. N Engl J Med 2018;378:1592–36.
1. Placenta accreta. Committee Opinion No. 529. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;120:207–11.